FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

California authorities identify final unknown victim of ‘Happy Face Killer’ Keith Jesperson after 34 years

New York Gov Hochul rejects Trump’s ‘Lake America’ renaming with blunt message

Maine meteorologist suffers giggle attack on live TV after prank backfires spectacularly

Defense Claims Lindsay Clancy ‘Never Did Anything Wrong in Her Life’ in Closing Argument

Report: Trump Admin Nearing ‘Massive’ Venezuelan Oil Deal

RNC threatens legal action against New Jersey officials over noncitizens on voter rolls: ‘On notice’

Social media erupts after cops reportedly raid home of Ilhan Omar’s son: ‘Not a good look’

Gov Shapiro sues Trump administration over ‘lifesaving reproductive care’ in escalating abortion battle

Watch: Hegseth Rights Another Biden Wrong – Upgrades Abbey Gate Heroes’ Awards After Previous Admin Wrongly Downgraded Them

Lutnick stumps for Trump’s Kennedy Center rebrand outside key court hearing

Restaurant Hands Dessert with Painful Birthday Message to Wheelchair-Bound Diner After Kitchen Staffer Misunderstands Instructions

US removes radioactive cancer-treatment material from Central American country over ‘dirty bomb’ risk

Embattled California Democrat to step aside as Dads Caucus chairman

White House silent on Iran-Oman Hormuz plan Tehran says would ban US warships

Socialist surge threatens Democrats in New Hampshire Senate race

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”